NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
04/04/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/04/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/04/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/04/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
2 | |
04/04/22 | 3/A | Initial statement of beneficial ownership of securities |
![]() |
2 | |
03/28/22 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
![]() |
7 | |
03/28/22 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() |
![]() ![]() ![]() |
159 |
03/24/22 | 8-K | Current report filing |
![]() |
![]() ![]() ![]() |
6 |
02/11/22 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
![]() |
5 | |
01/13/22 | 8-K | Current report filing |
![]() |
![]() ![]() ![]() |
28 |